Skip to main content
. 2011 Nov;179(5):2519–2532. doi: 10.1016/j.ajpath.2011.07.036

Table 1.

Differential miRNA Expression in Injury and Tolerance, Relative to Control

miRNA Injury Tolerance miRNA Injury Tolerance
miR10b 8.54 1.0 miR326 6.93 −5.27
miR21 44.58 21.66 miR328 1.4 1.22
miR-27a 2.5 −3.31 miR330 −3.89 −7.69
miR29a 1.86 1.18 miR374 −2.76 −10.1
miR30e 1.92 0.78 miR375 12.31 1.10
miR101 0.8 −3.5 miR381 −4.76 −6.58
miR103 0.99 −1.77 miR422b −4.33 −2.70
miR107 1.01 −2.35 miR425 2.16 1.05
miR125a 0.9 0.7 miR451 3.44 4.33
miR127 0.93 −1.50 miR487b 1.46 1.15
miR132 22.2 1.15 miR497 −2.35 −3.67
miR133b −3.76 −3.11 miR507 76.91 1.0
miR134 2.49 2.21 miR509 7.89 13.93
miR139 6.56 1.06 miR518b n.d ND
miR145 1.15 −1.61 miR518c n.d ND
miR146b 3.91 1.22 miR518d 143.92 70.40
miR148b 1.01 −2.16 miR520b −52.63 −39.21
miR153 6.65 0.85 miR520c n.d ND
miR181c 1.01 0.90 miR520g n.d ND
miR199a 7.50 1.49 miR532 1.47 0.83
miR200a 6.99 −3.14 miR629 1.0 2229
miR219 22.96 5.16 miR657 −22.2 −3.57
miR323 22.62 1.38

The miRNA was extracted from the ipsilateral CA3 subfield 24 hours after focal-onset status epilepticus in animals that had previously received either seizure preconditioning (tolerance) or no preconditioning (injury). Values represent the fold difference relative to control for miRNAs expressed in injury and tolerance.

ND, not detected (expression in injury and tolerance was below the 35 cycle cutoff).